Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE010B01027 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Zydus Lifescie Zydus Lifesciences Ltd. | BSE 921.80 5.30 (0.58%) | NSE 921.95 5.05 (0.55%) | Trade | Add

BSE Live

Jan 05, 16:01

921.80 5.30 (0.58%)

Volume

AVERAGE VOLUME

5-Day

14,091

10-Day

16,691

30-Day

18,202

10,642

Prev. Close

916.50
Open Price

916.85

Bid Price (Qty.)
922.00 (13)
Offer Price (Qty.)
922.95 (83)

NSE Live

Jan 05, 15:58

921.95 5.05 (0.55%)

Volume

AVERAGE VOLUME

5-Day

456,405

10-Day

461,981

30-Day

784,403

442,298

Prev. Close

916.90
Open Price

915.10

Bid Price (Qty.)
921.95 (54)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Zydus Lifesciences (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	14,590.10	10,317.60	8,421.20	7,590.00	7,436.70
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	14,590.10	10,317.60	8,421.20	7,590.00	7,436.70
Total Operating Revenues	15,116.30	10,818.70	8,731.60	7,981.90	7,780.00
Other Income	696.20	1,084.80	548.40	178.70	89.30
Total Revenue	15,812.50	11,903.50	9,280.00	8,160.60	7,869.30
EXPENSES
Cost Of Materials Consumed	2,787.10	3,001.40	2,703.50	2,629.00	2,346.40
Purchase Of Stock-In Trade	350.90	283.20	362.70	288.10	153.30
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-121.10	-131.70	105.10	-46.90	-148.30
Employee Benefit Expenses	1,762.20	1,507.50	1,321.90	1,204.90	1,147.30
Finance Costs	463.90	390.70	278.20	134.90	70.90
Depreciation And Amortisation Expenses	523.90	504.40	488.60	478.70	451.10
Other Expenses	2,600.90	2,099.60	1,784.00	1,988.70	1,972.60
Total Expenses	8,367.80	7,655.10	7,044.00	6,677.40	5,993.30
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	7,444.70	4,248.40	2,236.00	1,483.20	1,876.00
Exceptional Items	0.00	-8.60	-203.80	-319.30	-187.50
Profit/Loss Before Tax	7,444.70	4,239.80	2,032.20	1,163.90	1,688.50
Tax Expenses-Continued Operations
Current Tax	1,582.50	934.30	461.80	260.20	303.30
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	87.30	-136.00	41.20	45.80	-91.00
Tax For Earlier Years	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	1,669.80	798.30	503.00	306.00	212.30
Profit/Loss After Tax And Before ExtraOrdinary Items	5,774.90	3,441.50	1,529.20	857.90	1,476.20
Profit/Loss From Continuing Operations	5,774.90	3,441.50	1,529.20	857.90	1,476.20
Profit/Loss For The Period	5,774.90	3,441.50	1,529.20	857.90	1,476.20
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	57.39	34.01	15.06	8.38	14.42
Diluted EPS (Rs.)	57.39	34.01	15.06	8.38	14.42
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	0.00	0.00	0.00	0.00	0.00
Indigenous Raw Materials	0.00	0.00	0.00	0.00	0.00
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	301.90	607.30	253.00	358.50	0.00
Tax On Dividend	0.00	0.00	0.00	0.00	0.00
Equity Dividend Rate (%)	1,100.00	300.00	600.00	250.00	350.00